JPX · 4519.T
Chugai Pharmaceutical Co., Ltd.
¥6,822+¥169 (+2.54%)
Chugai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.24% below the high.
Loading market information…
JPX · 3046.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
JINS HOLDINGS Inc.’s quoted price sits in the lower half of its reported 52-week range, 35.36% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
JINS HOLDINGS Inc.’s forward annual dividend is ¥114 per share, paid semi-annual. The forward yield is 1.88% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
JINS HOLDINGS Inc.’s next earnings report is currently expected on Jan 8, 2027, with estimated earnings per share of ¥40. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow JINS HOLDINGS Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
JINS HOLDINGS Inc. is a Japanese corporation, operating through its subsidiaries, primarily involved in the design, manufacturing, wholesale, and retail of optical products and various fashion accessories. Its product portfolio includes a range of eyeglasses and lenses, alongside its innovative JINS MEME line, which allows users to monitor their physical and mental well-being. Beyond its core optical business, the firm also provides a selection of accessories for both genders, encompassing items like bags and headwear. Furthermore, it holds interests in agricultural contracting. JINS HOLDINGS maintains a global retail presence, with stores operating across Japan, mainland China, the U.S., Taiwan, and Hong Kong. Established in Tokyo, Japan, in 1988, the company operated as JINS Inc. until July 2019, when it adopted its current designation, JINS HOLDINGS Inc.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:34 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q3 2025 |
|---|
| Jul 11, 2025 |
| ¥107-5.21% vs estimate |
| ¥24.98B-0.03% vs estimate |
| Q2 2025 | Apr 11, 2025 | ¥106+26.4% vs estimate | ¥23.78B+2.76% vs estimate |
|---|
| Q1 2025 | Jan 10, 2025 | ¥56+17.27% vs estimate | ¥21.06B+0.5% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥6,822+¥169 (+2.54%)
Chugai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.24% below the high.
¥6,651+¥180 (+2.78%)
Takeda Pharmaceutical Company Limited’s quoted price sits in the upper half of its reported 52-week range, 0.91% below the high.
¥26,210-¥120 (-0.46%)
HOYA Corporation’s quoted price sits in the lower half of its reported 52-week range, 13.78% below the high.
¥12,015-¥270 (-2.2%)
Otsuka Holdings Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.1% below the high.
¥2,754+¥137 (+5.21%)
Daiichi Sankyo Company, Limited’s quoted price sits in the lower half of its reported 52-week range, 30.19% below the high.
¥2,571+¥58 (+2.31%)
Astellas Pharma Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.37% below the high.
¥2,405+¥36 (+1.5%)
Terumo Corporation’s quoted price sits in the upper half of its reported 52-week range, 10.58% below the high.
¥2,093+¥67 (+3.31%)
Japan Eyewear Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.42% below the high.
